Andrew Jurgensen1, Abd Assalam Qannus1, Aditi Gupta1,2. 1. Division of Nephrology, Kidney Institute and Center for Transplantation, Kansas City, KS. 2. Alzheimer's Disease Center, University of Kansas Medical Center, Kansas City, KS.
Abstract
PURPOSE OF THE REVIEW: Cognitive impairment is common in kidney transplant recipients and affects quality of life, graft survival, morbidity, and mortality. In this review article we discuss the epidemiology, diagnosis, pathophysiology and future directions for cognitive impairment in kidney transplantation. We describe the potential role of pre-transplant cognition, immunosuppression and peri-transplant factors in post -transplant cognitive impairment. RECENT FINDINGS: A majority of patients with kidney transplant have cognitive impairment. Cognitive impairment affects both pre-transplant evaluation and post-transplant outcomes. Failure to identify patients with cognitive impairment can withhold appropriate care and timely intervention. SUMMARY: Cognitive impairment is common in kidney transplant and affects outcomes. Studies addressing modifiable risk factors and possible interventions to slow cognitive decline in patients with kidney disease are needed.
PURPOSE OF THE REVIEW: Cognitive impairment is common in kidney transplant recipients and affects quality of life, graft survival, morbidity, and mortality. In this review article we discuss the epidemiology, diagnosis, pathophysiology and future directions for cognitive impairment in kidney transplantation. We describe the potential role of pre-transplant cognition, immunosuppression and peri-transplant factors in post -transplant cognitive impairment. RECENT FINDINGS: A majority of patients with kidney transplant have cognitive impairment. Cognitive impairment affects both pre-transplant evaluation and post-transplant outcomes. Failure to identify patients with cognitive impairment can withhold appropriate care and timely intervention. SUMMARY: Cognitive impairment is common in kidney transplant and affects outcomes. Studies addressing modifiable risk factors and possible interventions to slow cognitive decline in patients with kidney disease are needed.
Authors: Christine E Haugen; Nadia M Chu; Hao Ying; Fatima Warsame; Courtenay M Holscher; Niraj M Desai; Miranda R Jones; Silas P Norman; Daniel C Brennan; Jacqueline Garonzik-Wang; Jeremy D Walston; Adam W Bingaman; Dorry L Segev; Mara McAdams-DeMarco Journal: Clin J Am Soc Nephrol Date: 2019-03-19 Impact factor: 8.237
Authors: L Kramer; C Madl; F Stockenhuber; W Yeganehfar; E Eisenhuber; K Derfler; K Lenz; B Schneider; G Grimm Journal: Kidney Int Date: 1996-03 Impact factor: 10.612
Authors: Manjula Kurella Tamura; Virginia Wadley; Kristine Yaffe; Leslie A McClure; George Howard; Rodney Go; Richard M Allman; David G Warnock; William McClellan Journal: Am J Kidney Dis Date: 2008-06-30 Impact factor: 8.860
Authors: Niels D Prins; Ewoud J van Dijk; Tom den Heijer; Sarah E Vermeer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler Journal: Arch Neurol Date: 2004-10
Authors: E Sherwood Brown; Dixie J Woolston; Alan Frol; Leonardo Bobadilla; David A Khan; Margaret Hanczyc; A John Rush; James Fleckenstein; Evelyn Babcock; C Munro Cullum Journal: Biol Psychiatry Date: 2004-03-01 Impact factor: 13.382
Authors: Mariel Nöhre; Maximilian Bauer-Hohmann; Felix Klewitz; Eva-Marie Kyaw Tha Tun; Uwe Tegtbur; Lars Pape; Lena Schiffer; Martina de Zwaan; Mario Schiffer Journal: Front Psychiatry Date: 2019-10-31 Impact factor: 4.157